Browse by Audience
Skip to content
Papers of the Week
CGRP Targeting Therapy for Chronic Migraine-Evidence from Clinical Trials and Real-world Studies.
Abstract
Monoclonal antibodies against calcitonin gene-related peptide (CGRP) or its receptor have become part of the standard treatment for migraine in clinical practice. The current review focuses on the clinical evidence of CGRP monoclonal antibodies in patients with chronic migraine (CM), including more challenging cases.